targeting dna repair defect brca mutant cells therapeutic strategy 
brca1 brca2 important dna double-strand break repair homologous recombination mutations genes predispose breast cancers polyadp-ribose polymerase parp enzyme involved base excision repair key pathway repair dna single-strand breaks show brca1 brca2 dysfunction unexpectedly profoundly sensitizes cells inhibition parp enzymatic activity resulting chromosomal instability cell cycle arrest subsequent apoptosis seems inhibition parp leads persistence dna lesions normally repaired homologous recombination results illustrate different pathways cooperate repair damage suggest targeted inhibition particular dna repair pathways may allow design specific less toxic therapies cancer 
